ESR1 and breast carcinoma: SDC1 expression did not change significantly in patients with breast cancer at different prechemotherapy stages, different BMN grades, or estrogen receptor (ER) ER+/ER– genotypes as revealed in GEO profiles GDS4056 and GDS4057 (Figure 1B).